Editorial
doi: 10.1053/euhj.2000.2230.
The EMIP project. European Myocardial Infarction Project
- PMID: 10973762
- DOI: 10.1053/euhj.2000.2230
Item in Clipboard
Editorial
The EMIP project. European Myocardial Infarction Project
Eur Heart J.
2000 Sep.
No abstract available
Comment in
-
About EMIP-FR and reperfusion damage in AMI: a comment to the comment.Eur Heart J. 2001 Jun;22(11):973-5; author reply 978. doi: 10.1053/euhj.2000.2489. Eur Heart J. 2001. PMID: 11428823 No abstract available.
-
The EMIP-FR Study: the evolution of scientific background as a non-controlled parameter.Eur Heart J. 2001 Jun;22(11):975-7; author reply 978. doi: 10.1053/euhj.2000.2528. Eur Heart J. 2001. PMID: 11428824 No abstract available.
-
Trimetazidine and reperfusion injury.Eur Heart J. 2001 Jun;22(11):975; author reply 978. doi: 10.1053/euhj.2000.2529. Eur Heart J. 2001. PMID: 11428825 No abstract available.
-
Trimetazidine in AMI.Eur Heart J. 2001 Jun;22(11):977-8. doi: 10.1053/euhj.2000.2527. Eur Heart J. 2001. PMID: 11428826 No abstract available.
-
Comments on EMIP-FR study's editorial.Eur Heart J. 2001 Aug;22(15):1359. doi: 10.1053/euhj.2001.2539. Eur Heart J. 2001. PMID: 11465969 No abstract available.
Comment on
-
Effect of 48-h intravenous trimetazidine on short- and long-term outcomes of patients with acute myocardial infarction, with and without thrombolytic therapy; A double-blind, placebo-controlled, randomized trial. The EMIP-FR Group. European Myocardial Infarction Project--Free Radicals.Eur Heart J. 2000 Sep;21(18):1537-46. doi: 10.1053/euhj.1999.2439. Eur Heart J. 2000. PMID: 10973768 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
